Data for ST000075
Metabolite structure | All data | F1 | F2 | F3 |
---|---|---|---|---|
1-Hexadecanoyl-sn-glycero-3-phosphocholine | 159685.89 | 451929.35 | 435164.23 | |
Acylcarnitine C16:0 | 21364.37 | 32451.43 | 6323.92 | |
Acylcarnitine C18:0 | 11809.02 | 7970.76 | 2373.96 | |
Acylcarnitine C18:1 | 35208.58 | 49256.31 | 7208.65 | |
Acylcarnitine C18:2 | 39360.24 | 34834.98 | 6776.99 | |
CE (18:1) | 28656.18 | 43522.20 | 66052.82 | |
CE (18:2) | 407276.26 | 424584.17 | 585267.03 | |
CE (20:4) | 216169.52 | 370586.89 | 151473.74 | |
CE (22:6) | 211027.31 | 327497.38 | 36468.39 | |
Cholesterol | 100969.18 | 108109.51 | 88652.73 | |
DG (36:3) | 10120.18 | 8838.82 | 23769.09 | |
LPC (15:0) | 11002.87 | 15425.41 | 14083.18 | |
LPC (16:0) | 1809907.04 | 4020622.85 | 3707298.99 | |
LPC (16:1) | 10251.52 | 39538.10 | 24607.77 | |
LPC (18:0) | 1209972.23 | 2132088.84 | 1237951.73 | |
LPC (18:1) | 202453.02 | 470707.35 | 396176.03 | |
LPC (18:2) | 904554.30 | 1463042.32 | 622011.50 | |
LPC (20:1) | 6211.85 | 29347.80 | 6970.74 | |
LPC (20:2) | 7874.71 | 17200.69 | 8604.37 | |
LPC (20:3) | 15718.36 | 40685.21 | 34090.55 | |
LPC (20:4) | 251784.16 | 538739.94 | 148213.51 | |
LPC (20:5) | 61019.60 | 131895.17 | 32012.67 | |
LPC (22:6) | 89688.61 | 196529.31 | 27446.40 | |
N-Stearoyl-4-sphingenyl-1-O-phosphorylcholine | 10720.81 | 10604.53 | 64053.77 | |
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholine | 173160.19 | 585454.88 | 616157.76 | |
Oleoyl ethylamide | 11292.40 | 16678.91 | 17090.83 | |
PC (16:0/16:0) | 283720.69 | 430391.67 | 403472.56 | |
PC (18:1/16:0) | 1768824.64 | 4139445.42 | 4622426.46 | |
PC 32:0 | 33408.36 | 57157.61 | 49731.91 | |
PC (32:1) | 30829.34 | 105729.37 | 231240.66 | |
PC 32:1 | 5221.54 | 17243.12 | 33382.49 | |
PC (32:2) | 15936.60 | 35170.63 | 68429.22 | |
PC (33:1) | 18336.10 | 42752.61 | 46447.58 | |
PC (33:2) | 108727.97 | 108464.32 | 77426.35 | |
PC 33:2 | 17187.55 | 18046.16 | 15122.54 | |
PC (34:0) | 60258.12 | 113616.18 | 73992.57 | |
PC (34:2) | 11890947.82 | 12977547.96 | 10734962.65 | |
PC (34:3) | 108729.93 | 361920.54 | 130611.51 | |
PC (34:4) | 5480.11 | 9587.73 | 22545.90 | |
PC (35:1) | 40468.34 | 52703.62 | 52237.96 | |
PC (35:2) | 563912.91 | 400404.58 | 192454.55 | |
PC (35:3) | 39931.17 | 67518.22 | 23278.83 | |
PC (35:4) | 26897.75 | 29462.17 | 22538.29 | |
PC (36:2) | 10179391.84 | 9281407.87 | 6971099.41 | |
PC 36:2 | 1043312.09 | 992211.51 | 957422.71 | |
PC (36:3) A | 2788449.41 | 2598314.78 | 2119810.27 | |
PC (36:4) | 5291030.55 | 7999911.52 | 5464810.59 | |
PC 36:4 | 725215.32 | 791744.72 | 803488.97 | |
PC (36:5) C | 963858.46 | 901519.50 | 983165.53 | |
PC (36:6) | 5206.80 | 9950.88 | 8344.19 | |
PC (37:2) | 152672.18 | 261219.22 | 22737.74 | |
PC (37:4) | 185611.32 | 203308.17 | 75305.10 | |
PC (37:6) | 17418.61 | 22396.86 | 7283.82 | |
PC (38:2) | 72365.52 | 189906.96 | 82549.35 | |
PC (38:4) A | 5153405.05 | 6403824.16 | 3492966.79 | |
PC (38:5) A | 841081.60 | 1557016.20 | 726636.42 | |
PC 38:6 | 758959.09 | 1076571.03 | 480884.63 | |
PC (38:6) A | 4383620.16 | 7099324.97 | 2315583.77 | |
PC (39:6) | 95044.89 | 76111.49 | 25903.78 | |
PC (40:4) | 48691.41 | 100519.96 | 92988.53 | |
PC 40:6 | 365986.71 | 436445.98 | 110532.15 | |
PC (40:6) A | 2200897.30 | 2485681.21 | 627411.08 | |
PC (40:7) | 651415.63 | 1380525.18 | 142085.91 | |
PC (40:8) | 137411.37 | 170192.67 | 18255.11 | |
PC 42:10 | 26877.31 | 41980.11 | 5441.32 | |
PC-O (32:0) (plasmanyl/plasmenyl) | 14137.36 | 23991.13 | 57568.27 | |
PC-O (34:1) (plasmanyl/plasmenyl) | 54320.48 | 62892.75 | 96370.49 | |
PC-O (34:2) (plasmanyl/plasmenyl) | 47469.25 | 55512.29 | 189531.70 | |
PC-O (36:2) (plasmanyl/plasmenyl) | 19570.98 | 19348.10 | 47593.65 | |
PC-O (36:3) (plasmanyl/plasmenyl) | 20053.01 | 16068.63 | 76339.50 | |
PC-O (36:4) (plasmanyl/plasmenyl) | 102859.07 | 112024.10 | 426148.84 | |
PC-O (36:5) (plasmanyl/plasmenyl) | 96231.67 | 87121.18 | 419047.13 | |
PC-O (38:4) (plasmanyl/plasmenyl) | 33784.67 | 33079.24 | 186808.17 | |
PC-O (38:6) (plasmanyl/plasmenyl) | 58687.58 | 47052.93 | 77061.99 | |
PC-O (40:4) (plasmanyl/plasmenyl) | 12008.28 | 10631.04 | 23222.09 | |
PC-O (40:7) (plasmanyl/plasmenyl) | 14640.20 | 13884.61 | 14553.00 | |
PC-O (40:8) (plasmanyl/plasmenyl) | 16942.80 | 17338.87 | 52474.25 | |
PE (38:6) | 35405.51 | 57425.72 | 12746.64 | |
PE-O (36:5) (plasmanyl/plasmenyl) | 10530.47 | 14826.31 | 35362.85 | |
PE-O (38:5) (plasmanyl/plasmenyl) | 10803.51 | 9591.25 | 46425.25 | |
plasmenyl-PE 40:6 | 14084.38 | 16281.39 | 13832.81 | |
SM (33:1) | 35868.26 | 54463.00 | 65018.41 | |
SM (34:0) | 24064.09 | 21383.51 | 94646.64 | |
SM 34:1 | 133418.18 | 144939.37 | 529029.15 | |
SM (d16:1/20:0) | 59409.24 | 56257.49 | 340072.29 | |
SM (d16:1/20:1) | 51132.04 | 44307.11 | 463741.63 | |
SM (d18:1/14:0) | 6531.76 | 9929.49 | 109338.87 | |
SM (d18:1/16:0) | 689482.38 | 715203.20 | 2163554.24 | |
SM (d18:1/16:1) | 85280.11 | 106993.65 | 318101.35 | |
SM (d18:2/23:0) | 13073.39 | 41957.97 | 54092.01 | |
SM (d18:2/24:1) | 105359.19 | 190308.88 | 408358.08 | |
SM (d38:1) | 15516.73 | 27161.58 | 186933.61 | |
SM (d40:1) | 108475.93 | 247042.51 | 452486.75 | |
SM (d40:2) A | 25693.49 | 62603.50 | 259329.46 | |
SM (d41:1) | 55980.85 | 67830.74 | 151794.68 | |
SM (d42:1) | 87055.90 | 124956.16 | 282042.72 | |
TG (46:0) | 12799.16 | 8806.09 | 74053.30 | |
TG (48:0) | 168102.04 | 53015.17 | 253346.47 | |
TG (48:1) | 32895.98 | 36308.81 | 453315.89 | |
TG (48:2) | 50838.84 | 39494.35 | 308457.79 | |
TG (49:1) | 29148.78 | 14840.91 | 51773.51 | |
TG (49:2) | 64495.50 | 23782.13 | 34303.79 | |
TG (50:0) | 106566.12 | 29163.95 | 141722.96 | |
TG (50:1) | 596797.33 | 292848.72 | 1858023.29 | |
TG (50:2) | 1439639.15 | 633506.15 | 1676585.72 | |
TG (50:3) | 172718.63 | 317141.32 | 789022.40 | |
TG (50:4) | 68879.75 | 68262.78 | 122848.75 | |
TG (51:1) | 18154.79 | 6800.60 | 28836.15 | |
TG (51:2) | 95440.31 | 39354.73 | 118579.43 | |
TG (51:3) | 79629.22 | 59878.54 | 88654.95 | |
TG (51:4) | 106031.70 | 50303.92 | 24525.73 | |
TG (52:0) | 45640.94 | 17231.45 | 39626.23 | |
TG (52:1) | 262138.18 | 73978.85 | 620237.52 | |
TG (52:2) | 1724786.09 | 1416399.03 | 4495063.87 | |
TG (52:3) | 3760426.91 | 3727299.12 | 5955397.58 | |
TG (52:4) | 5172235.64 | 3969394.10 | 3127245.46 | |
TG (52:5) | 536077.36 | 320743.25 | 220107.06 | |
TG (52:6) | 56316.24 | 39363.78 | 24398.67 | |
TG (53:3) | 110107.64 | 53166.54 | 83215.85 | |
TG (53:4) | 217744.64 | 73769.75 | 62161.10 | |
TG (53:5) | 43995.23 | 34856.76 | 13602.16 | |
TG (54:1) | 55560.15 | 21497.69 | 78934.28 | |
TG (54:2) | 329511.53 | 112396.33 | 541164.89 | |
TG (54:3) | 1861135.65 | 908969.70 | 1585554.93 | |
TG (54:4) | 3447276.96 | 1630573.51 | 1924238.72 | |
TG (54:5) | 3995062.92 | 1881998.91 | 1350762.05 | |
TG (54:6) | 3458341.31 | 978186.85 | 299252.46 | |
TG 54:7;TG(16:0/18:2/20:5) | 446800.46 | 88335.65 | 19932.40 | |
TG (54:8) | 22090.77 | 11897.22 | 3458.72 | |
TG 55:4 | 23298.16 | 9683.82 | 3454.96 | |
TG (56:1) | 14022.75 | 9312.77 | 18677.82 | |
TG (56:2) | 32361.53 | 20260.37 | 21962.86 | |
TG (56:3) | 82967.25 | 60875.33 | 41193.26 | |
TG (56:4) | 46828.49 | 55463.93 | 16252.59 | |
TG (56:5) | 98037.62 | 68846.67 | 46723.23 | |
TG (56:6) | 109467.53 | 120757.66 | 62922.64 | |
TG (56:7) | 781657.50 | 754634.52 | 188621.21 | |
TG (56:8) | 1313923.99 | 725049.90 | 48550.63 | |
TG (58:10) | 911932.26 | 397198.83 | 14745.51 | |
TG (58:2) | 12543.13 | 7317.54 | 12606.59 | |
TG (58:3) | 14091.51 | 7173.16 | 9819.25 | |
TG (58:4) A | 29713.79 | 24278.52 | 7657.73 | |
TG 58:5 | 19677.44 | 15896.20 | 7040.06 | |
TG (58:6) | 22281.96 | 20926.38 | 7285.11 | |
TG (58:8) | 692105.70 | 255231.49 | 27305.81 | |
TG (58:9) | 824660.50 | 408829.51 | 26189.86 |
Factors:
F1 | Diagnosis:diabetic |
F2 | Diagnosis:non-diabetic |
F3 | Diagnosis:QC - quality check sample |